Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningxia Tairui Pharmaceutical is a China-based veterinary pharmaceutical manufacturer focused on the research, production, and global sale of veterinary active pharmaceutical ingredients, formulations, premixes, and feed additives. The company is best known for large-scale antibiotic fermentation and small-molecule anti-infective products including tylosin, tilmicosin, tiamulin fumarate, and erythromycin thiocyanate. It operates as an export-oriented, high-tech enterprise with substantial manufacturing scale in Ningxia and sales into more than 80 countries and regions. Tairui appears to be primarily a commercial manufacturing business rather than a clinical-stage drug developer, with its activity centered on industrial production, regulatory certifications, and global supply of veterinary medicines. The company also has subsidiaries involved in downstream antibiotic and fermentation products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningxia Tairui Pharmaceutical.